Interference of Cryptococcus neoformans with human neutrophil migration

Advances in Experimental Medicine and Biology

Volumn 531, Issue , 2003, Pages 315-339

  Walenkamp, Annemiek M E ^a   Ellerbroek, Pauline ^a   Scharringa, Jelle ^a   Rijkers, Eva ^a   Hoepelman, Andy I M ^a   Coenjaerts, Frank E J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIRETROVIRUS AGENT; CYTOKINE; FLUCONAZOLE; FLUCYTOSINE; IMMUNOSUPPRESSIVE AGENT;

CLINICAL FEATURE; CONFERENCE PAPER; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; FUNGUS; FUNGUS ISOLATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; NEUTROPHIL CHEMOTAXIS; PATHOGENESIS; PRIORITY JOURNAL; TREATMENT OUTCOME; YEAST;

FILOBASIDIELLA NEOFORMANS; FUNGI; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0041883706     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0059-9_27     Document Type: Conference Paper

References (109)

1. Aguirre, K., Havell, E.A., Gibson, G.W., and Johnson, L.L., 1995, Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect. Immun. 63: 1725-1731.
2. Ali, H. et al., 1994, Regulation of stably transfected platelet activating facto receptor in RBL-2H3 cells. Role of multiple G proteins and receptor phosphorylation. J. Biol. Chem. 269: 24557-24563.
3. Almeida, G.M., Andrade, R.M., and Bento, C.A., 2001, The capsular polysaccharides of Cryptococcus neoformans activate normal CD4(+) T cells in a dominant Th2 pattern. J. Immunol. 167: 5845-5851.
4. Amatruda, T.T., Gerard, N.P., Gerard, C., and Simon, M.I., 1993, Specific interactions of chemoattractant factor receptors with G-proteins. J. Biol. Chem. 268: 10139-10144.
5. Andrian, U. von, et al., 1991, Two-step model of leukocyte-endothelial cell interaction in inflammation: distinct roles for LECAM-1 and the leukocyte beta-2 integrins in vivo. Proc. Natl. Acad. Sci. U. S. A. 88: 7538-7542.
6. Appelbaum, E., and Shtokalko, S., 1957, Cryptococcus meningitis arrested wit amphotericin B. Ann. Intern. Med. 47: 346-351.
7. Baker, R.D., 1976, The primary pulmonary lymph node complex of cryptococcosis. Am. J. Clin. Pathol. 65: 83-92.
8. Barone, F.C., and Feuerstein, G.Z., 1999, Inflammatory mediators and stroke: new opportunities for novel therapeutics. J. Cereb. Blood Flow Metab. 19: 819-834.
9. Bloomfield, N., Gordon, M.A., and Elmendorf, D.F., 1963, Detection of Cryptococcus neoformans antigen in body fluids by latex particle agglutination. Proc. Soc. Exp. Biol. Med. 114: 64-67.
10. Bolanos, B. & Mitchell, T.G., 1989, Phagocytosis and killing of Cryptococcus neoformans by rat alveolar macrophages in the absence of serum. J. Leukoc. Biol. 46: 521-528.
11. Brockhaus, M. et al., 1990, Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc. Natl. Acad. Sci. U. S. A. 87: 3127-3131.
12. Campbell, G.D., 1966, Primary pulmonary cryptococcosis. Am. Rev. Respir. Dis. 94: 236-243.
13. Carlos, T.M., and Harlan, J.M., 1994, Leukocyte-endothelial adhesion molecules. Blood 84: 2068-2101
14. Chaka, W. et al., 1997a, Induction of TNF-alpha in human peripheral blood mononuclearcells by the mannoprotein of Cryptococcus neoformans involve human mannose binding protein. J. Immunol. 159: 2979-2985.
15. Chaka, W. et al., 1997b, Cryptococcus neoformans and cryptococcal glucuronoxylomannan, galactoxylomannan, and mannoprotein induce different levels of tumor necrosis factor alpha in human peripheral blood mononuclear cells. Infect. Immun. 65: 272-278.
16. Chaka, W., et al., 1997c, Cytokine profiles in cerebrospinal fluid of human immunodeficiency virus-infected patients with cryptococcal meningitis: no leukocytosis despite high interleukin-8 levels. University of Zimbabwe Meningitis Group. J. Infect. Dis. 176: 1633-1636.
17. Cauley, L.K., and Murphy, J.W., 1979, Response of congenitally athymic (nude) and phenotypically normal mice to Cryptococcus neoformans infection. Infect. Immun. 23: 644-651.
18. Chang, Y.C., and Kwon-Chung, K.J., 1994, Complementation of a capsule-deficient Mutation of Cryptococcus neoformans restores its virulence. Mol. Cell Biol. 14: 4912-4919.
19. Chang, Y.C., Penoyer, L.A., and Kwon-Chung, K.J., 1996, The second capsule gene of Cryptococcus neoformans, CAP64, is essential for virulence. Infect. Immun. 64: 1977-1983.
20. Cherniak, R., 1988, Current topics in medical mycology (McGuinness, M.R., ed.) Springer-Verlag, New York.
21. Cherniak, R., and Sundstrom, J.B., 1994, Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect. Immun. 62: 1507-1512.
22. Clumeck, N., et al., 1984, Acquired immunodeficiency syndrome in African patients. N. Engl. J. Med. 310: 492-497.
23. Coenjaerts, F.E. et al., 2001, Potent inhibition of neutrophil migration by Cryptococcal mannoprotein-4-induced desensitization. J. Immunol. 167: 3988-3995.
24. Collins, H.L., and Bancroft, G.J., 1992, Cytokine enhancement of complement- dependent phagocytosis by macrophages: synergy of tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans. Eur. J. Immunol. 22: 1447-1454.
25. Cross, C.E., and Bancroft, G.J., 1995, Ingestion of acapsular Cryptococcus neoformans occurs via mannose and beta-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form. Infect. Immun. 63: 2604-2611.
26. Crouch, E., Hartshorn, K., and Ofek, I., 2000, Collectins and pulmonary innate immunity. Immunol. Rev. 173: 52-65.
27. Delfino, D. et al., 1997, Interleukin-6 production by human monocytes stimulate with Cryptococcus neoformans components. Infect. Immun. 65: 2454-2456.
28. Diamond, R.D., Root, R.K. & Bennett, J.E. Factors influencing killing of Cryptococcus neoformans by human leukocytes in vitro. J. Infect. Dis. 125: 367-376 (1972).
29. Dong, Z.M., and Murphy, J.W., 1993, Mobility of human neutrophils in response to Cryptococcus neoformans cells, culture filtrate antigen, and individual components of the antigen. Infect. Immun. 61: 5067-5077
30. Dong, Z.M., and Murphy, J.W., 1995, Intravascular cryptococcal culture filtrate (CneF) and its major component, glucuronoxylomannan, are potent inhibitors of leukocyte accumulation. Infect. Immun. 63: 770-778.
31. Dong, Z.M., and Murphy, J.W., 1996, Cryptococcal polysaccharides induce L-selectin shedding and tumor necrosis factor receptor loss from the surface of human neutrophils. J. Clin. Invest. 97: 689-698.
32. Drouhet, E. & Segretain, G., 1951, Inhibition de la Migration Leucocytaire In Vitro par un Polyoside Capsulaire de Torulopsis (Cryptococcus) neoformans. Annales de l'Institute Pasteur 81: 674-676.
33. Dustin, M.L., Rothlein, R., Bhan, A.K., Dinarello, C.A., and Springer, T.A., 1986, Induction by IL 1 and interferon-gamma: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 137: 245-254.
34. Eng, R.H., Bishburg, E., Smith, S.M., and Kapila, R., 1986, Cryptococcal infections in patient with acquired immune deficiency syndrome. Am. J. Med. 81: 19-23.
35. Evans, N., 1922, Torula infection. Report of two cases. Calif. State J. Med. 20, 383-385.
36. Feuerstein, G.Z., Wang, X. & Barone, F.C., 1997, Inflammatory gene expression in cerebral schemia and trauma. Potential new therapeutic targets. Ann. N. Y. Acad. Sci. 825, 179-193.
37. Fromtling, R.A., Shadomy, H.J., and Jacobson, E.S., 1982, Decreased virulence in stable, acapsular mutants of Cryptococcus neoformans. Mycopathologia 79: 23-29.
38. Graybill, J.R., and Drutz, D.J., 1978, Host defence in cryptococcosis. II. Cryptococcosis in the nude mouse. Cell Immunol. 40: 263-274.
39. Graybill, J.R., Mitchell, L., and Drutz, D.J., 1979, Host defence in cryptococcosis. III. Protection of nude mice by thymus transplantation. J. Infect. Dis. 140: 546-552.
40. Heyderman, R.S. et al., 1998, Cryptococcal meningitis in human immunodeficiency virus-infected patients in Harare, Zimbabwe. Clin. Infect. Dis. 26: 284-289.
41. Hakim, J.G. et al., 2000, Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients. AIDS 14: 1401-1407.
42. Huffnagle, G.B. et al., 1995, The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ T cells during a pulmonary Cryptococcus neoformans infection. J. Immunol. 155: 4790-4797.
43. Huffnagle, G.B. et al., 1996, Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. J. Immunol. 157: 4529-4536.
44. Huffnagle, G.B. et al., 1997, Macrophage inflammatory protein-1alpha (M1P-1alpha) is required for the efferent phase of pulmonary cell-mediated immunity to a Cryptococcus neoformans infection. J. Immunol. 159: 318-327.
45. Huffnagle, G.B., and Lipscomb, M.F., 1998, Cells and cytokines in pulmonary cryptococcosis. Res. Immunol. 149: 387-396.
46. Ibrahim, A.S. et al., 1995, Adherence to and damage of endothelial cells by Cryptococcus neoformans in vitro: role of the capsule. Infect. Immun. 63: 4368-4374.
47. Jacobson, E.S. & Tinnell, S.B., 1993, Antioxidant function of fungal melanin. J. Bacteriol. 175: 7102-7104.
48. James, P.G. & Cherniak, R, 1992, Galactoxylomannans of Cryptococcus neoformans. Infect. Immun. 60: 1084-1088 (1992).
49. Kerkering, T.M., Duma, R.J., and Shadomy, S., 1981, The evolution of pulmonary cryptococcosis: clinical implications from a study of 41 patients with and without compromising host factors. Ann. Intern. Med. 94: 611-616.
50. Khoury, M.B., et al., 1984, Thoracic cryptococcosis: immunologic competence and radiologic appearance. AJR Am. J. Roentgenol. 142: 893-896.
51. Kishimoto, T.K., Jutila, M.A., Berg, E.L., and Butcher, E.C., 1989, Neutrophil Mac-1 and MEL-14 adhesion proteins inversely regulated by chemotactic factors. Science 245: 1238-1241.
52. Knoke, M., and Schwesinger, G., 1994, One hundred years ago: the history of cryptococcosis in Greifswald. Medical mycology in the nineteenth century. Mycoses 37: 229-233.
53. Kovacs, J.A., et al., 1985, Cryptococcosis in the acquired immunodeficiency syndrome. Ann. Intern. Med. 103: 533-538.
54. Kozel, T.R., and Gotschlich, E.C., 1982, The capsule of Cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. J. Immunol. 129: 675-1680.
55. Kozel, T.R., Pfrommer, G.S., Guerlain, A.S., Highison, B.A. and Highison, G.J., 1988, Role of the capsule in phagocytosis of Cryptococcus neoformans. Rev. Infect. Dis. 10 (Suppl 2): S436-S439.
56. Lantz, M., Bjornberg, F., Olsson, I. and Richter, J., 1994, Adherence of neutrophils induces release of soluble tumor necrosis factor receptor forms. J. Immunol. 152: 1362-1369.
57. Laichalk, L.L. et al., 1996, Tumor necrosis factor mediates lung antibacterial host defence in murine Klebsiella pneumonia. Infect. Immun. 64: 5211-5218.
58. Leib, S.L., and Tauber, M.G., 1999, Pathogenesis of bacterial meningitis. Infect. Dis. Clin. North Am. 13, 527-5vi.
59. Levitz, S.M., Tabuni, A., Kornfeld, H., Reardon, C.C., and Golenbock, D.T., 1994, Production of tumor necrosis factor alpha in human leukocytes stimulated by Cryptococcus neoformans. Infect. Immun. 62: 1975-1981.
60. Levitz, S.M., and Farrell, T.P., 1990, Growth inhibition of Cryptococcus neoformans by cultured human monocytes: role of the capsule, opsonins, the culture surface, and cytokines. Infect. Immun. 58: 1201-1209.
61. Lipovsky, M.M., van Elden, L.J., Walenkamp, A.M., Dankert, J., and Hoepelman, A.I., 1998a, Does the capsule component of the Cryptococcus neoformans glucuronoxylomannan impair transendothelial migration of leukocytes in patients with cryptococcal meningitis? [letter]. J. Infect. Dis. 178: 1231-1232.
62. Lipovsky, M.M. et al., 1998b, Cryptococcal glucuronoxylomannan induces interleukin (IL)-8 production by human microglia but inhibits neutrophilmigration toward IL-8. J. Infect. Dis. 177: 260-263.
63. Lipovsky, M.M., et al., 2000, Cryptococcal glucuronoxylomannan delays translocation of leukocytes across the blood-brain barrier in an animal model of acute bacterial meningitis. J. Neuroimmunol. 111: 10-14.
64. Luscinskas, F.W. et al., 1992, In vitro inhibitory effect of IL-8 and other chemoattractants on neutrophil-endothelial adhesive interactions. J. Immunol. 49: 2163-2171.
65. Macdonald, J.C. et al., 1998, Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in. AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy. J. Infect. Dis. 177: 1182-1187.
66. Maher, D., and Mwandumba, H., 1994, Cryptococcal meningitis in Lilongwe and Blantyre, Malawi. J. Infect. 28: 59-64.
67. Malaviya, R., Ikeda, T., Ross, E. and Abraham, S.N., 1996, Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-alpha [see comments]. Nature 381: 77-80.
68. Matsushima, K., and Oppenheim, J.J., 1989, Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF. Cytokine 1: 2-13.
69. Miller, M.F., and Mitchell, T.G., 1991, Killing of Cryptococcus neoformans strains by human neutrophils and monocytes. Infect. Immun. 59: 24-28.
70. Mitchell, T.G., and Perfect, J.R., 1995, Cryptococcosis in the era of AIDS - 100 years after the discovery of Cryptococcus neoformans. Clin. Microbiol. Rev. 8: 515-548.
71. Mody, C.H., Tyler, C.L., Sitrin, R.G., Jackson, C., and Toews, G.B., 1991, Interferon-gamma activates rat alveolar macrophages for anticryptococcal activity. Am. J. Respir. Cell Mol. Biol. 5: 19-26.
72. Neilson, J.B., Ivey, M.H., and Bulmer, G.S., 1978, Cryptococcus neoformans: pseudohyphal forms surviving culture with Acanthamoeba polyphaga. Infect. Immun. 20: 262-266.
73. Nelson, R.D., Quie, P.G., and Simmons, R.L., 1975, Chemotaxis under agarose: a new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J. Immunol. 115: 1650-1656.
74. Neumann, B., et al., 1996, Crucial role of 55-kilodalton TNF receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration. J. Immunol. 156: 1587-1593.
75. Nwokolo, N.C., Fisher, M., Gazzard, B.G., and Nelson, M.R., 2001, Cessation of secondary prophylaxis in patients with cryptococcosis. AIDS 15: 1438-1439.
76. Oppenheim, J., Zachariae, C.O., Mukaida, N., and Matsushima, K., 1991, Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu. Rev. Immunol. 9: 617-648.
77. Pantoni, L., Sarti, C. and Inzitari, D., 1998, Cytokines and cell adhesion molecules in cerebral ischemia: experimental bases and therapeutic perspectives. Arterioscler. Thromb. Vasc. Biol. 18: 503-513.
78. Pierson, P.H., 1917, Torula in man. Report of a case with necropsy findings. J. Am. Med. Assoc. 69: 2179-2181.
79. Polacheck, I., Hearing, V.J. and Kwon-Chung, K.J., 1982, Biochemical studies of phenoloxidase and utilization of catecholamines in Cryptococcus neoformans. J. Bacteriol. 150: 1212-1220.
80. Porteu, F., and Hieblot, C., 1994, Tumor necrosis factor induces a selective shedding of its p75 receptor from human neutrophils. J. Biol. Chem. 269: 2834-2840.
81. Powell, K.E., Dahl, B.A., Weeks, R.J., and Tosh, F.E., 1972, Airborne Cryptococcus neoformans: particles from pigeon excreta compatible with alveolar deposition. J. Infect. Dis. 125: 412-415.
82. Quagliarello, V.J., and Scheld, W.M., 1997, Treatment of bacterial meningitis [see comments]. N. Engl. J. Med. 336: 708-716.
83. Reiss, E., Chemiak, R., Eby, R. and Kaufman, L., 1984, Enzyme immunoassay detection of IgM to galactoxylomannan of Cryptococcus neoformans. Diagn. Immunol. 2: 109-115.
84. Retini, C. et al., 1996, Capsular polysaccharide of Cryptococcus neoformans induces proinflammatory cytokine release by human neutrophils. Infect. Immun. 64: 2897-2903.
85. Rollot, F., et al., 2001, Discontinuation of secondary prophylaxis against cryptococcosis in patients with AIDS receiving highly active antiretroviral therapy. AIDS 15: 1448-1449.
86. Roseff, S.A., and Levitz, S.M., 1993, Effect of endothelial cells on phagocyte-mediated anticryptococcal activity. Infect. Immun. 61, 3818-3824.
87. Rusk, G.Y., and Farnell, F.J., 1912, Systemic oidiomycosis. A study of two cases developing terminal oidiomycetic meningitis. Univ. Calif. Publ. Pathol. 2: 47-58.
88. Saag, M.S., et al., 2000, Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin. Infect. Dis. 30: 710-718.
89. Sabroe, I., Williams, T.J., Hebert, C.A., and Collins, P.D., 1997, Chemoattractant cross-desensitization of the human neutrophil IL-8 receptor involves receptor internalization and differential receptor subtype regulation. J. Immunol. 158: 1361-1369.
90. Sanfelice, F., 1894, Contributo alla morfologia e biologia dei blastomiceti che si sviluppano nei succhi di alcuni frutti. Ann. Inst. Igien. Univ. Roma 4: 463-495.
91. Sanfelice, F., 1895, Sull'azione patogena dei blastomiceti. Ann. Inst. Igien. Univ. Roma 5: 239-262.
92. Sarosi, G.A., Parker, J.D., Doto, I.L., and Tosh, F.E., 1969, Amphotericin B in cryptococcal meningitis: long-term results of treatment. Ann. Intern. Med. 71: 1079-1087.
93. Schelenz, S., Malhotra, R., Sim, R.B., Holmskov, U., and Bancroft, G.J., 1995, Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells. Infect. Immun. 63: 3360-3366.
94. Schneider, M.M., Borleffs, J.C., Stolk, R.P., Jaspers, C.A., and Hoepelman, A.I., 1999, Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy. Lancet 353: 201-203.
95. Simonet, W.S. et al., 1994, Long-term impaired neutrophil migration in mice overexpressing human interleukin-8. J. Clin. Invest. 94: 1310-1319.
96. Snow, R.M., and Dismukes, W.E., 1975, Cryptococcal meningitis: diagnostic value of cryptococcal antigen in cerebrospinal fluid. Arch. Intern. Med. 135: 1155-1157.
97. Sorvillo, F., et al., 1997, Incidence and factors associated with extrapulmonary cryptococcosis among persons with HIV infection in Los Angeles County. AIDS 11: 673-679.
98. Springer, T.A., 1994, Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76, 301-314.
99. Strieter, R.M., et al., 1996, quot. 'The good, the bad, and the ugly.'quot. The role of chemokines in models of human disease. J. Immunol. 156: 3583-3586.
100. Suster, B., Akerman, M., Orenstein, M., and Wax, M.R., 1986, Pulmonary manifestations of AIDS: review of 106 episodes. Radiology 161, 87-93.
101. Tuomanen, E.I., Saukkonen K., Sande, S., Cioffe, C. and Wright, S.D., 1989, Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes. J. Exp. Med. 170: 959-969.
102. Turner, S.H., Cherniak, R. and Reiss, E., 1984, Fractionation and characterization of galactoxylomannan from Cryptococcus neoformans. Carbohydr. Res. 125: 343-349.
103. Vartivarian, S.E., et al., 1993, Regulation of cryptococcal capsular polysaccharide by iron. J. Infect. Dis. 167: 186-190.
104. Vicaut, E., Hou, X., Payen, D., Bousseau A., and Tedgui, A., 1991, Acute effects of tumor necrosis factor on the microcirculation in rat cremaster muscle. J. Clin. Invest. 87: 1537-1540.
105. Walenkamp, A.M. et al., 1999a, Cryptococcus neoformans and its cell wall components induce similar cytokine profiles in human peripheral blood mononuclear cells despite differences in structure. FEMS Immunol. Med. Microbiol. 26: 309-318.
106. Walenkamp, A.M., Verheul, A.F., Scharringa, J., and Hoepelman, I.M., 1999b, Pulmonary surfactant protein A binds to Cryptococcus neoformans without promoting phagocytosis. Eur. J. Clin. Invest. 29: 83-92.
107. Weinberg, P.B., Becker, S., Granger, D.L., and Koren, H.S., 1987, Growthinhibition of Cryptococcus neoformans by human alveolar macrophages. Am. Rev. Respir. Dis. 136: 1242-1247.
108. Williamson, J.D., Silverman, J.F., Mallak, C.T., and Christie, J.D., 1996, Atypical cytomorphologic appearance of Cryptococcus neoformans: a report of five cases. Acta Cytol. 40: 363-370.
109. Wold, L.E., et al., 1980, Massive antigenemia during disseminated cryptococcosis. Mayo Clin. Proc. 55: 513-515.